Influenza immunization in systemic lupus eruthematosus. A double-blind trial

Area of Science:

• Immunology
• Rheumatology
• Vaccinology

Background:

• Systemic lupus erythematosus (SLE) is an autoimmune disease affecting multiple organs.
• Patients with SLE may have altered immune responses and are at risk for infections.
• Influenza vaccination is recommended for immunocompromised individuals, but safety in SLE requires evaluation.

Purpose of the Study:

• To evaluate the safety and immunogenicity of inactivated bivalent influenza vaccine in patients with SLE.
• To assess the impact of influenza vaccination on disease activity and organ function in SLE patients.

Main Methods:

• A double-blind, randomized study involving 40 patients with SLE.
• Participants received either influenza vaccine or saline placebo.
• Disease activity, organ function, and antibody titers were monitored over 20 weeks.

Main Results:

• No significant difference in major organ function or disease flares between vaccinated and placebo groups.
• Lower pre-immunization antibody titers and reduced response to vaccination in SLE patients compared to controls.
• Individual assessment of immune response is crucial.

Conclusions:

• Influenza vaccination is safe for patients with SLE.
• While immune responses may be blunted, vaccination does not exacerbate disease activity.
• Influenza immunization can be safely administered to SLE patients.